The lower the share price, the easier the CR. And with current cash burn, thats not far way.
I said a while back that any announcement would result in a small price hike followed by a decline, ie exactly what has happened. Recall that retail investors hold this stock and such investors need a diet of positive announcements to stay invested. We all like the tech but poor comms combined with failure to incentivise patients to accelerate the trial means the stock will only go lower as retail investors see better opportunities elsewhere.
IBX Price at posting:
4.6¢ Sentiment: Hold Disclosure: Held
